C79.70
C79.70 — Secondary malignant neoplasm of unspecified adrenal gland
Billable / specific codeICD-10-CM
C79.70 is a billable, specific ICD-10-CM code for secondary malignant neoplasm of unspecified adrenal gland. It is valid for submission on a claim.
Risk adjustment
C79.70 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 17 Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic4.209 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C79.70 is named in 19 Medicare coverage policies — 19 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
- A53101Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID® Update
Related codes at this level
Codes that share C79.7. If C79.70 is not quite right, the correct code is usually one of these.
Questions about C79.70
- Is C79.70 a billable ICD-10-CM code?
- Yes. C79.70 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C79.70 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of ill-defined, other secondary and unspecified sites (C76-C80).